Blood Dna Protocol
Blood Dna Protocol - Related Videos
09:15
DNA-based Fish Species Identification Protocol
0 Views •
Cited by 10 •
2010
This publication describes how to use the Agilent Fish Species Identification System to identify the species of a fish by extracting DNA and performing PCR and RFLP analysis.
12:03
Protocols for C-Brick DNA Standard Assembly Using Cpf1
0 Views •
Cited by 4 •
2017
CRISPR-associated protein Cpf1 can be guided by a specially designed CRISPR RNA (crRNA) to cleave double-stranded DNA at desired sites, generating sticky ends. Based on this characteristic, a DNA assembly standard (C-Brick) was established, and a protocol detailing its use is described here.
07:16
A Simple Chelex Protocol for DNA Extraction from Anopheles spp.
0 Views •
Cited by 58 •
2013
A rapid and affordable way to extract quality malaria parasite and vector DNA from mosquito specimens is described. Capitalizing on chelating properties of Chelex resin, the simple method enables genotyping of malaria parasites in mosquito mid-gut and salivary gland phases, as well as molecular identification of the Anopheles sibling species by PCR.
10:43
A Practical and Novel Method to Extract Genomic DNA from Blood Collection Kits for Plasma Protein Preservation
0 Views •
Cited by 4 •
2013
We are describing a new method of isolating genomic DNA from whole blood collected for plasma/serology. After plasma collection, the compacted blood is usually discarded. Our novel method represents a significant improvement over existing methods and makes DNA and plasma available from a single collection, without requesting additional blood.
05:26
A Standardized Liquid Biopsy Preanalytical Protocol for Downstream Circulating-Free DNA Applications
0 Views •
Cited by 3 •
2022
The liquid biopsy has revolutionized our approach to oncology translational studies, with sample collection, quality, and storage being crucial steps for its successful clinical application. Here we describe a standardized and validated protocol for downstream circulating-free DNA applications that can be applied in most translational research laboratories.
FAQs
Leukocytes provide the cellular source of genomic DNA, whereas other blood components do not serve the same role in the isolation workflow described here. Separating this fraction before lysis concentrates the relevant genetic material and reduces interference from non-target blood components. That separation supports more consistent DNA recovery for later genetic analyses, including PCR, genotyping, and sequencing.
Lysis disrupts both cellular and nuclear membranes, allowing genomic DNA to move into the surrounding solution. This step is essential because the DNA is enclosed within leukocytes and their nuclei before processing. Effective membrane disruption creates access to the genetic material, while the following purification stages remove released proteins and other contaminants before the DNA is recovered.
Proteins and other contaminants can remain associated with the sample after membrane disruption, so purification is needed before downstream use. Removing these unwanted components helps produce DNA that is more suitable for PCR, genotyping, sequencing, and variant analysis. The quality of this cleanup influences whether subsequent assays receive usable genetic material and produce reproducible results.
Consistent handling across samples is central to maintaining DNA yield, integrity, and reproducibility. The major workflow features identified in the protocol are effective leukocyte separation, complete lysis, removal of proteins and contaminants, and appropriate DNA elution or storage. Variation in these stages can change the amount or quality of material available for later genetic measurements.
The workflow progresses through several linked stages: leukocytes are separated from other blood components, cellular and nuclear membranes are lysed, proteins and contaminants are removed, and the DNA is then purified. The recovered material is either eluted for immediate downstream analysis or stored for later use. Keeping these stages ordered supports consistent preparation across samples.
Purified blood DNA is useful when researchers need genomic material for PCR, genotyping, sequencing, variant analysis, or genetic identification. These applications allow investigators to examine inherited variation, disease-associated changes, or patterns relevant to population genetics. The same preparation workflow can therefore support both targeted assays and broader analyses of genetic differences among samples.
By producing genomic DNA from blood in a consistent form, the protocol supplies material for examining genetic differences between individuals or samples. Downstream analyses can use that material to investigate inherited variation, identify disease-associated changes, and contribute to population-genetics studies. Reliable processing is important because differences in DNA quality or yield can affect comparisons and interpretation.